J9340 — Injection, thiotepa, 15 mg
J9340 is a HCPCS Level II code for injection, thiotepa, 15 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on June 30, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J9340 on June 30, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J9340
- Long descriptor
- Injection, thiotepa, 15 mg
- Short descriptor
- Thiotepa injection
- Added
- January 1, 1984
- Terminated
- June 30, 2025
- BETOS
- O1D
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J9340
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J9340 is not quite right, the correct code is very often within a few positions of it.
- J9326Injection, telisotuzumab vedotin-tllv, 1 mg
- J9328Injection, temozolomide, 1 mg
- J9329Injection, tislelizumab-jsgr, 1mg
- J9330Injection, temsirolimus, 1 mg
- J9331Injection, sirolimus protein-bound particles, 1 mg
- J9332Injection, efgartigimod alfa-fcab, 2mg
- J9333Injection, rozanolixizumab-noli, 1 mg
- J9334Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
- J9341Injection, thiotepa (tepylute), 1 mg
- J9342Injection, thiotepa, not otherwise specified, 1 mg
- J9345Injection, retifanlimab-dlwr, 1 mg
- J9347Injection, tremelimumab-actl, 1 mg
- J9348Injection, naxitamab-gqgk, 1 mg
- J9349Injection, tafasitamab-cxix, 2 mg
- J9350Injection, mosunetuzumab-axgb, 1 mg
- J9351Injection, topotecan, 0.1 mg
Questions about J9340
What is HCPCS code J9340?
J9340 is a HCPCS Level II code for injection, thiotepa, 15 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J9340?
The CMS HCPCS file marks J9340 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J9340 still valid?
No. J9340 was terminated on June 30, 2025 and should not be used on new claims.